The Institute of Physiology offers consumers services for the use of transcranial magnetic stimulation techniques for the treatment of general developmental disorders and specific developmental and speech disorders, including autism in children aged 3–9 years, under an outsourcing agreement and is seeking partners interested in a distribution services agreement.

Treatment of general developmental disorders and specific developmental and speech disorders, including autism in children aged 3–9 years using the transcranial magnetic stimulation (TMS) method, which is based on the hardware effect of an alternating magnetic field on the patient's brain in order to modulate the excitability of brain structures and achieve a therapeutic effect. The course of treatment includes 10–30 procedures.

The method is designed for psychiatrists-narcologists, physiotherapists-narcologists, physiotherapists, functional diagnostics doctors of healthcare organizations providing medical care in inpatient and/or outpatient settings and/or day care departments.

Information is posted in the "Album of Promising Developments of Organizations of the National Academy of Sciences of Belarus for the Real Sector of the Economy" (2023), pp. 373-374. (in Russian)

There are TMS methods for treating adult patients. This method was developed for treating children and has no analogues in the Republic of Belarus. It is effective in 80% of patients with disorders of psychomotor development of various genesis, including autism. If the instructions are followed, the method is safe. If necessary, the location of the inductor is adjusted and/or the intensity of the stimulus used is reduced in accordance with the instructions for use.

The method has been introduced into practical healthcare of the Republic of Belarus (Vitebsk Regional Clinical Center for Psychiatry and Narcology (07.08.2019); consultative and outpatient department of the State Institution "Republican Scientific and Practical Center for Mental Health" of the Ministry of Health of the Republic of Belarus (23.01.2020).

Instructions for use "Method of treatment of general developmental disorders, specific disorders of speech and language development by transcranial magnetic stimulation" T. V. Dokukina, M. I. Tukalo, I. I. Khvostova, T. A. Mityukova, O. E. Polulyakh, O. Yu. Zakharevich, A. I. Martynenko, reg. No. 047-0419 dated 04.25 2019 (in Russian)

The Institute is a leading scientific institution coordinating physiological research in the Republic of Belarus.

The institute successfully carries out fundamental and applied research aimed at developing methods for the prevention and correction of pathological conditions of hypoxic, ischemic and inflammatory genesis, and develops new devices and methods for their therapeutic and prophylactic use. The main scientific activity of the departments is currently focused on studying the mechanisms of the formation of pathological conditions of the body (primarily hypoxic and neurodestructive) and substantiating new technologies for prevention, treatment and rehabilitation. Particular attention is paid to the development of complex methods for the treatment of malignant tumors using metabolic blockade effectors and high-intensity pulsed magnetic fields and methods for controlling the proliferation of tumor cells based on changes in the functional state of neuroreceptors in vitro and in vivo, as well as the development of a method for immunotherapy of patients suffering from pancreatic cancer. , using autologous dendritic cells primed with tumor antigens and elucidating new mechanisms of tumor formation, substantiation of prevention methods. Studies of the molecular mechanisms of proliferation, differentiation and oncogenesis are being carried out; physiological and therapeutic effect of physical factors and the development of new technologies of physiotherapy and physiotherapy equipment and experimental analysis of positive and negative aspects of the use of nanoparticles and heterocyclic compounds in biomedical technologies. The neurophysiological bases of dysregulation of the functions of internal organs during ischemia of the nervous tissue of various origins are being studied. Works on the physiology of nutrition and sports are being carried out. Preclinical studies of drugs and nanomaterials are underway. Research is being carried out on the safety of biosubstances, biotherapeutic agents, pharmacological complexes and medical products on the basis of agreements with manufacturing enterprises and research institutions. The staff of the Institute conducts research on the mechanisms of interaction between neurons and glial cells in normal and pathological conditions. The functional role of biological preparations (platelet-rich plasma, suspension of mitochondria, mesenchymal stem cells, etc.) in the activation of reparative processes in strokes and brain injuries, ischemia of the lower extremities is being studied. Methods for stable remote monitoring of vital human functions (heart, blood vessels, respiration, temperature, motor activity, brain activity) are being developed. Particular attention is paid to the study of the functional role of the extracellular matrix and stem cells in the development of neoplasms. Cell technologies are being developed for the treatment of malignant diseases. The Institute also evaluates the therapeutic and therapeutic-prophylactic properties of natural mineral waters and the effectiveness of pre- and probiotics - food, food supplements.

Close scientific cooperation is carried out with scientists from Russia, China and Uzbekistan.

Consumers interested in purchasing services for the use of transcranial magnetic stimulation for the treatment of general developmental disorders and specific developmental and speech disorders, including autism in children aged 3-9 years, under an outsourcing agreement.

Partners interested in purchasing services for the use of transcranial magnetic stimulation for the treatment of general developmental disorders and specific developmental and speech disorders, including autism in children aged 3-9 years, under a distribution services agreement.